Heredi-TEK™
Heredi-TEK™ is a comprehensive genetic screening designed to identify actionable risks for a broad spectrum of serious hereditary conditions. By focusing on 81 genes recommended by the American College of Medical Genetics and Genomics (ACMG), this test enables individuals and healthcare providers to implement proactive prevention and tailored care.
Order TestWho Is Heredi-TEK™ For?
Cardiovascular Risk
Patients with family histories of sudden cardiac arrest, arrhythmias, or familial hypercholesterolemia.
Metabolic Disorders
Individuals seeking to understand genetic predispositions to serious metabolic conditions.
Other Risks
Those with a family history of actionable inherited cancer, connective tissue, neurological, multisystem syndromes.
Proactive Health Screening
Healthy individuals wanting a baseline of their medically actionable genetic risks.
Medically Actionable Insights
ACMG-Recommended Panel: Focuses specifically on the American College of Medical Genetics and Genomics list of actionable genes.
Clear Clinical Actionability: Only includes variants where preventative measures or treatments exist.
Comprehensive Overview: Covers a diverse range of critical health areas in a single screening.
What Does Heredi-TEK™ Test For?
Heredi-TEK™ screens 84 ACMG-recommended genes, which cover 6 health domains
Hereditary Cancers
Multiple cancers implicated in genes such as BRCA1, BRCA2, TP53, MLH1, MSH2, VHL, and PTEN.
Cardiovascular Diseases
Such as familial hypercholesterolemia (LDLR, APOB) and cardiomyopathies (MYH7, MYBPC3).
Vascular & Connective Tissue Disorders
Such as Marfan syndrome and related vascular conditions (FBN1, COL3A1).
Metabolic Conditions
Fabry disease (GLA), Wilson disease (ATP7B), and related actionable metabolic conditions.
Muscle & Neurological Disorders
Such as neurofibromatosis (NF2) and muscular dystrophies (LMNA, TTN).
Endocrine & Multisystem Syndromes
Such as MEN1, RET, VHL, NF2, and TSC1/TSC2.
Clinical Utility & Implementation Tips
Screening Efficiency: Use a short intake form to quickly flag eligible patients during routine consultations.
Standardized Integration: Incorporate Heredi-TEK™ into baseline checkups for proactive patient management.
Enhanced Risk Profiling: Consider pairing Heredi-TEK™ with PRS-TEK™ to provide a comprehensive assessment of both rare monogenic risks and common polygenic risks.
Clear Referral Paths: Establish pre-defined pathways to genetics specialists for patients receiving positive findings.
How It Works
A simple, guided process from consultation to clinically actionable reporting.
Ready to Integrate Heredi-TEK™ Into Your Practice?
Contact our team to learn how our tests can enhance your clinical offerings and improve patient outcomes.
Contact Sales Request Information